{"id":533261,"date":"2021-09-01T08:04:14","date_gmt":"2021-09-01T12:04:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/"},"modified":"2021-09-01T08:04:14","modified_gmt":"2021-09-01T12:04:14","slug":"nucana-to-participate-in-three-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/","title":{"rendered":"NuCana to Participate in Three Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">EDINBURGH, United Kingdom, Sept.  01, 2021  (GLOBE NEWSWIRE) &#8212; NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in three upcoming virtual investor conferences.<\/p>\n<p>Event: Citi\u2019s 16th Annual BioPharma Virtual Conference<br \/>Dates: September 8-10, 2021<\/p>\n<p>Event: H.C. Wainwright 23rd Annual Global Investment Conference<br \/>Dates: September 13-15, 2021<\/p>\n<p>Event: Oppenheimer\u2019s Virtual Fall Healthcare Life Sciences &amp; MedTech Summit<br \/>Presentation Date: Wednesday, September 22, 2021<br \/>Presentation Time: 9:05 AM ET<\/p>\n<p>A pre-recorded webcast of the presentation at the H.C. Wainwright 23rd Annual Global Investment Conference will be made available on the Company\u2019s website starting on Monday, September 13, 2021, at 7:00 AM ET. The presentation at the Oppenheimer Virtual Fall Healthcare Life Sciences &amp; MedTech Summit will be webcast live. Both presentations will be available for replay under \u201cEvents &amp; Presentations\u201d in the Investors section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a4DmcixjW4uNeh0q83eK1Z1mxaM3kBAojBjSa4f-ixL8p1JRX0YxQwX2FL9mw4MZqAaQhmzhLjMpbxAmZCfZBQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.nucana.com<\/a>.<\/p>\n<p>\n        <strong>About NuCana<\/strong>\n      <\/p>\n<p>NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. While these conventional agents remain part of the standard of care for the treatment of many solid and hematological tumors, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilizing our proprietary technology, we are developing new medicines, ProTides, designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. NuCana\u2019s robust pipeline includes three ProTides in clinical development. Acelarin and NUC-3373, are new chemical entities derived from the nucleoside analogs gemcitabine and 5-fluorouracil, respectively, two widely used chemotherapy agents. Acelarin is in a Phase III study for patients with advanced biliary tract cancer. NUC-3373 is in a Phase I study for the potential treatment of a wide range of patients with advanced solid tumors and a Phase Ib study for patients with metastatic colorectal cancer. Our third ProTide, NUC-7738, is a transformation of a novel nucleoside analog (3\u2019-deoxyadenosine) and is in a Phase I study for patients with advanced solid tumors.<\/p>\n<p>\n        <strong><br \/>\n          <em>Forward-Looking Statements<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <em>This press release may contain \u201cforward-looking\u201d statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on the beliefs and assumptions and on information currently available to management of NuCana plc (the \u201cCompany\u201d). All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements concerning the Company\u2019s planned and ongoing clinical studies for the Company\u2019s product candidates and the potential advantages of those product candidates, including Acelarin, NUC-3373 and NUC-7738; the initiation, enrollment, timing, progress, release of data from and results of those planned and ongoing clinical studies; the Company\u2019s goals with respect to the development, regulatory pathway and potential use, if approved, of each of its product candidates; and the utility of prior non-clinical and clinical data in determining future clinical results. In some cases, you can identify forward-looking statements by terminology such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cpredicts,\u201d \u201cpotential\u201d or \u201ccontinue\u201d or the negative of these terms or other comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company\u2019s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 20-F for the year ended December 31, 2020 filed with the Securities and Exchange Commission (\u201cSEC\u201d) on March 4, 2021, and subsequent reports that the Company files with the SEC. Forward-looking statements represent the Company\u2019s beliefs and assumptions only as of the date of this press release. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Except as required by law, the Company assumes no obligation to publicly update any forward-looking statements for any reason after the date of this press release to conform any of the forward-looking statements to actual results or to changes in its expectations.<\/em>\n      <\/p>\n<p>For more information, please contact:<\/p>\n<p>NuCana plc<br \/>Hugh S. Griffith<br \/>Chief Executive Officer<br \/>+44 131 357 1111<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UXeOxER_Isy5hvTZGX-4Ys6MLosPKG68giUr1ezXRBqqOJVCPb3EttHqYDKVu90kTdbGDh2mynpOzaJJIqdTFA==\" rel=\"nofollow noopener\" target=\"_blank\">info@nucana.com<\/a><\/p>\n<p>Westwicke, an ICR Company<br \/>Chris Brinzey<br \/>+1 339-970-2843<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KbhKP-B84tozrpLHl0ydYFNyca1muBP1f8WRi0QCeCzO8nE0ZVYPWbwKqzSTCsqgt8DQA6B8r2uOhGMWqusjPpoBe0BBt8jcqPHJOTYNWwb3hvhwtk3IFSvPQxaWNtTJ\" rel=\"nofollow noopener\" target=\"_blank\">chris.brinzey@westwicke.com<\/a><\/p>\n<p>RooneyPartners<br \/>Marion Janic<br \/>+1 212-223-4017<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UPYt4FQB_OPUzszjsERvznYJLQw58MxkOhXK5iCj62hmbke4Tub_m8wY_m1ZgP8N52uu1IwolWKeK-YAyAprkkZUyNv9aSb0RVfyZmN7F7w=\" rel=\"nofollow noopener\" target=\"_blank\">mjanic@rooneyco.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NzgxMTVhNTgtZTczYS00NzZlLWE5NzYtODUwMjA0Zjg2MTU3LTExMDI4NjI=\/tiny\/NuCana-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EDINBURGH, United Kingdom, Sept. 01, 2021 (GLOBE NEWSWIRE) &#8212; NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in three upcoming virtual investor conferences. Event: Citi\u2019s 16th Annual BioPharma Virtual ConferenceDates: September 8-10, 2021 Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDates: September 13-15, 2021 Event: Oppenheimer\u2019s Virtual Fall Healthcare Life Sciences &amp; MedTech SummitPresentation Date: Wednesday, September 22, 2021Presentation Time: 9:05 AM ET A pre-recorded webcast of the presentation at the H.C. Wainwright 23rd Annual Global Investment Conference will be made available on the Company\u2019s website starting on Monday, September 13, 2021, at 7:00 AM ET. The presentation at the Oppenheimer Virtual Fall Healthcare Life Sciences &amp; MedTech &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NuCana to Participate in Three Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533261","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NuCana to Participate in Three Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NuCana to Participate in Three Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EDINBURGH, United Kingdom, Sept. 01, 2021 (GLOBE NEWSWIRE) &#8212; NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in three upcoming virtual investor conferences. Event: Citi\u2019s 16th Annual BioPharma Virtual ConferenceDates: September 8-10, 2021 Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDates: September 13-15, 2021 Event: Oppenheimer\u2019s Virtual Fall Healthcare Life Sciences &amp; MedTech SummitPresentation Date: Wednesday, September 22, 2021Presentation Time: 9:05 AM ET A pre-recorded webcast of the presentation at the H.C. Wainwright 23rd Annual Global Investment Conference will be made available on the Company\u2019s website starting on Monday, September 13, 2021, at 7:00 AM ET. The presentation at the Oppenheimer Virtual Fall Healthcare Life Sciences &amp; MedTech &hellip; Continue reading &quot;NuCana to Participate in Three Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-01T12:04:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NuCana to Participate in Three Upcoming Investor Conferences\",\"datePublished\":\"2021-09-01T12:04:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/\"},\"wordCount\":745,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/\",\"name\":\"NuCana to Participate in Three Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=\",\"datePublished\":\"2021-09-01T12:04:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nucana-to-participate-in-three-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NuCana to Participate in Three Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NuCana to Participate in Three Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"NuCana to Participate in Three Upcoming Investor Conferences - Market Newsdesk","og_description":"EDINBURGH, United Kingdom, Sept. 01, 2021 (GLOBE NEWSWIRE) &#8212; NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in three upcoming virtual investor conferences. Event: Citi\u2019s 16th Annual BioPharma Virtual ConferenceDates: September 8-10, 2021 Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDates: September 13-15, 2021 Event: Oppenheimer\u2019s Virtual Fall Healthcare Life Sciences &amp; MedTech SummitPresentation Date: Wednesday, September 22, 2021Presentation Time: 9:05 AM ET A pre-recorded webcast of the presentation at the H.C. Wainwright 23rd Annual Global Investment Conference will be made available on the Company\u2019s website starting on Monday, September 13, 2021, at 7:00 AM ET. The presentation at the Oppenheimer Virtual Fall Healthcare Life Sciences &amp; MedTech &hellip; Continue reading \"NuCana to Participate in Three Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-01T12:04:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NuCana to Participate in Three Upcoming Investor Conferences","datePublished":"2021-09-01T12:04:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/"},"wordCount":745,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/","name":"NuCana to Participate in Three Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=","datePublished":"2021-09-01T12:04:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODI5MSM0MzgzNzA3IzIwOTEyOTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nucana-to-participate-in-three-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NuCana to Participate in Three Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533261"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533261\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}